ReShape Lifesciences Inc expected to post a loss of 34  cents a share - Earnings Preview

Vyome Holdings

06/05/2022 19:37

* ReShape Lifesciences Inc  RSLS.OQ   RSLS.O  is expected
to report results on May 10 (estimated).
    * The San Clemente California-based  company is expected to
report
revenue of $3.223 million, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for ReShape
Lifesciences Inc
is for a loss of 34 cents per share. For the same quarter last
year, the company reported a loss of $1.32 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $4.75​, above​ its last closing price
of $0.76. ​​​

This summary was machine generated May 6 at 18:37 GMT.  All
figures in US dollars  unless otherwise stated